Article
Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19
2021-05-18
Abstract excerpt
Computational Drug Repositioning aims at ranking and selecting existing drugs for use in novel diseases or existing diseases for which these drugs were not originally designed. Using vast amounts of available omic data in digital form within an in silico screening has the potential for speeding up considerably the shortlisting of promising candidates in response to outbreaks of diseases such as COVID-19 for which...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5013d4f-a091-525a-bc16-85b327ef5a35
- DOI
- 10.1101/2021.05.13.21257140
